Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2025

Conditions
Glioma, Mixed
Interventions
OTHER

Fasting

The study intervention consists of one fasting cycle of 72 hours prior to biopsy/resection. Depending on clinical condition, patients can be hospitalized during the course of the study (e.g. need for medical assistance due to immobilization). Patients in good clinical condition will be admitted on day 3.

Trial Locations (1)

60590

Dr. Senckenberg Institute of Neurooncology, University Medicine Fankfurt, Goethe-University, Frankfurt am Main

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Goethe University

OTHER